Independent Franchise Partners
US Equity Fund
US Equity Fund Portfolio 13F
Independent Franchise Partners Holdings Activity
- Portfolio value:
- $1.85B≈ (+$90M≈)
- Previous value:
- $1.76B≈
- # of changes:
- 27
- New positions:
- 1
- Reported for:
- 29 Dec 2023 (Q4)
- Latest filing date:
- 26 Feb 2024
US Equity Fund has disclosed a total of 27 changes to the portfolio in the (2023 Q4) SEC report(s): increased the number of shares of 2, bought 1 totally new and decreased the number of shares of 24 position(s).
What did Independent Franchise Partners invest in during 2023 Q4?
In the 2023 Q4 report(s) the following changes have been made to the top investments: (RBA) RB Global Inc (reduced shares -1.15%), (ZG) Zillow Group Inc (reduced shares -1.15%), (ICE) Intercontinental Exchange Inc (reduced shares -0.87%), (PM) Philip Morris International Inc (reduced shares -1.15%) and (BMY) Bristol-Myers Squibb Company (reduced shares -0.96%).
27 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Revvity Inc
|
new
|
+230,656
|
230,656
|
+1.36%
|
$109.31
|
+3.34%($112.96)
|
1.36%
|
2023 Q4
|
≈ 0.25 years
|
|
|
|
TransUnion
|
+20.62%
|
+160,044
|
936,316
|
+0.59%
|
$68.71
|
+14.82%($78.90)
|
3.47%
|
2022 Q1
|
≈ 2.00 years
|
|
|
|
TKO Group Holdings, Inc
|
+18.11%
|
+134,892
|
879,935
|
+0.59%
|
$81.58
|
+123.06%($181.97)
|
3.88%
|
2023 Q3
|
≈ 0.50 years
|
|
|
|
Estee Lauder Companies Inc
|
-0.86%
|
-2,592
|
297,817
|
-0.02%
|
$146.25
|
-42.29%($84.40)
|
2.35%
|
2023 Q3
|
≈ 0.50 years
|
|
|
|
Intercontinental Exchange Inc
|
-0.87%
|
-6,424
|
735,455
|
-0.05%
|
$128.43
|
+18.40%($152.06)
|
5.10%
|
2021 Q2
|
≈ 2.75 years
|
|
|
|
Aspen Technology Inc
|
-0.91%
|
-1,877
|
204,151
|
-0.02%
|
$220.15
|
|
2.43%
|
2023 Q2
|
≈ 0.75 years
|
|
|
|
BRITISH AMERICAN TOBACCO PLC
|
-0.91%
|
-18,545
|
2,012,022
|
-0.03%
|
$29.26
|
+107.80%($60.80)
|
3.18%
|
2019 Q3
|
≈ 4.50 years
|
|
|
|
Corteva Inc
|
-0.91%
|
-13,649
|
1,480,846
|
-0.04%
|
$47.92
|
+67.54%($80.28)
|
3.83%
|
2019 Q4
|
≈ 4.25 years
|
|
|
|
Bristol-Myers Squibb Company
|
-0.96%
|
-16,838
|
1,736,448
|
-0.05%
|
$51.31
|
+26.91%($65.12)
|
4.81%
|
2019 Q3
|
≈ 4.50 years
|
|
|
|
Booking Holdings Inc
|
-1.01%
|
-6,075
|
597,550
|
-0.05%
|
$141.89
|
+36.80%($194.10)
|
4.58%
|
2019 Q3
|
≈ 4.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.